Antibacterial Action of Mixed-ligand Imidazole - Phenanthroline Copper Complex; Anti-Infective Agents; Vol. 16, iss. 2

Bibliografiske detaljer
Parent link:Anti-Infective Agents
Vol. 16, iss. 2.— 2018.— [P. 100-103]
Hovedforfatter: Plotnikov E. V. Evgeny Vladimirovich
Corporate Authors: Национальный исследовательский Томский политехнический университет Инженерная школа природных ресурсов Отделение химической инженерии, Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)
Andre forfattere: Plotnikov V. M. Vladimir Mikhaylovich
Summary:Title screen
Background: Multidrug Resistance (MDR) of microorganisms is the biggest pharmacological challenge, despite plenty of modern antibiotics. Obviously, new classes of antimicrobial drugs against MDR pathogens need to be developed. Objective: This work aimed to investigate the antibacterial properties of the novel copper-based complex - bisimidazoles - (1,10) phenanthroline cuprum (II) dichloride - [CuPhenIm2]Cl2. Material & Methods: The complex - bisimidazoles-(1,10)phenanthroline cuprum (II) dichloride - [Cu- Phen-Im2]Cl2 was synthetized for the experiment. The structure was identified by elemental analysis and IR spectroscopy. The antibacterial properties of the copper complex were investigated by agar diffusion and serial dilution methods with the following bacteria strains Staphylococcus haemolyticus (ATCC 29970), Staphylococcus aureus (ATCC 25923), Proteus vulgaris (ATCC 13315), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Mycobacterium bovis (Valle). Antituberculosis activity test included evaluation of bacterial growth on Lowenstein Jensen media with a serial dilution of copper complex, within an observation period of 90 days. Results: The prospect copper complex showed significant antibacterial activity. The most susceptible to copper action were strains of S.haemolyticus and S.aureus. The bisimidazoles - (1,10) phenanthroline cuprum (II) dichloride revealed moderate bactericidal action against Mycobacteria bovis. Conclusion: Most of the tested bacterial pathogens were highly susceptible to the novel copper substance. A detailed assessment of the biological action in in vivo is further required.
Режим доступа: по договору с организацией-держателем ресурса
Sprog:engelsk
Udgivet: 2018
Fag:
Online adgang:http://dx.doi.org/10.2174/2211352516666180531075622
Format: Electronisk Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=659420

MARC

LEADER 00000naa0a2200000 4500
001 659420
005 20250321152407.0
035 |a (RuTPU)RU\TPU\network\27979 
090 |a 659420 
100 |a 20190218d2018 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Antibacterial Action of Mixed-ligand Imidazole - Phenanthroline Copper Complex  |f E. V. Plotnikov, V. M. Plotnikov 
203 |a Text  |c electronic 
300 |a Title screen 
330 |a Background: Multidrug Resistance (MDR) of microorganisms is the biggest pharmacological challenge, despite plenty of modern antibiotics. Obviously, new classes of antimicrobial drugs against MDR pathogens need to be developed. Objective: This work aimed to investigate the antibacterial properties of the novel copper-based complex - bisimidazoles - (1,10) phenanthroline cuprum (II) dichloride - [CuPhenIm2]Cl2. Material & Methods: The complex - bisimidazoles-(1,10)phenanthroline cuprum (II) dichloride - [Cu- Phen-Im2]Cl2 was synthetized for the experiment. The structure was identified by elemental analysis and IR spectroscopy. The antibacterial properties of the copper complex were investigated by agar diffusion and serial dilution methods with the following bacteria strains Staphylococcus haemolyticus (ATCC 29970), Staphylococcus aureus (ATCC 25923), Proteus vulgaris (ATCC 13315), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and Mycobacterium bovis (Valle). Antituberculosis activity test included evaluation of bacterial growth on Lowenstein Jensen media with a serial dilution of copper complex, within an observation period of 90 days. Results: The prospect copper complex showed significant antibacterial activity. The most susceptible to copper action were strains of S.haemolyticus and S.aureus. The bisimidazoles - (1,10) phenanthroline cuprum (II) dichloride revealed moderate bactericidal action against Mycobacteria bovis. Conclusion: Most of the tested bacterial pathogens were highly susceptible to the novel copper substance. A detailed assessment of the biological action in in vivo is further required. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Anti-Infective Agents 
463 |t Vol. 16, iss. 2  |v [P. 100-103]  |d 2018 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a copper-based complex 
610 1 |a phenanthroline 
610 1 |a imidazoles 
610 1 |a antibacterial drug 
610 1 |a staphylococcus 
610 1 |a mycobacterium bovis 
610 1 |a фенантролины 
610 1 |a имидазолы 
610 1 |a антибактериальные препараты 
610 1 |a стафилококки 
700 1 |a Plotnikov  |b E. V.  |c chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of Chemical Sciences  |f 1983-  |g Evgeny Vladimirovich  |3 (RuTPU)RU\TPU\pers\32469  |9 16417 
701 1 |a Plotnikov  |b V. M.  |g Vladimir Mikhaylovich 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Инженерная школа природных ресурсов  |b Отделение химической инженерии  |3 (RuTPU)RU\TPU\col\23513 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий (ИШХБМТ)  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537 
801 2 |a RU  |b 63413507  |c 20190218  |g RCR 
856 4 |u http://dx.doi.org/10.2174/2211352516666180531075622 
942 |c CF